Search Clinical Trials
597,593 trials
ID
Status
Phase
Title
Sponsor
NCT07753850
A Phase 2 Study of SL-325 in Crohn's Disease PatientsShattuck Labs, Inc.Not Yet RecruitingPhase 2
NCT07753850Not Yet Recruiting
Phase 2
A Phase 2 Study of SL-325 in Crohn's Disease PatientsShattuck Labs, Inc.
NCT07753863
Use of a Silicone Sensor to Protect Fragile Neonatal Skin in Moderately Preterm Infants Needing Continuous Monitoring: the PRO-NEO-SKIN (Protect Neonatal Skin) Pilot StudyPaolo Manzoni Study GroupNot Yet RecruitingNot Applicable
NCT07753863Not Yet Recruiting
Not Applicable
Use of a Silicone Sensor to Protect Fragile Neonatal Skin in Moderately Preterm...Paolo Manzoni Study Group
NCT07754604
Effects of Mental Fatigue Duration on Cortical Activity and Jump PerformanceInonu UniversityCompletedNot Applicable
NCT07754604Completed
Not Applicable
Effects of Mental Fatigue Duration on Cortical Activity and Jump PerformanceInonu University
NCT07753824
A Phase II Study of Ivonescimab Combined With Intraperitoneal Paclitaxel in Patients With High-Grade Metastatic Appendiceal Adenocarcinoma (AA)Cancer Prevention Research Institute of TexasNot Yet RecruitingPhase 2
NCT07753824Not Yet Recruiting
Phase 2
A Phase II Study of Ivonescimab Combined With Intraperitoneal Paclitaxel in Pati...Cancer Prevention Researc...
NCT07754292
Off-Label Treatment With Immune Checkpoint Inhibitor BlockadeMedical College of WisconsinNot Yet RecruitingPhase 2
NCT07754292Not Yet Recruiting
Phase 2
Off-Label Treatment With Immune Checkpoint Inhibitor BlockadeMedical College of Wiscon...
NCT07755579
Effect of Autologous Ear Cartilage Micrografting in Knee OsteoarthritisOrthosera Kft.Active Not RecruitingNot Applicable
NCT07755579Active Not Recruiting
Not Applicable
Effect of Autologous Ear Cartilage Micrografting in Knee OsteoarthritisOrthosera Kft.
NCT07754175
A Multicenter, Open-Label, Single-Arm Extension Study to Evaluate the Safety and Efficacy of FURESTEM-OA-Kit Inj. in Knee Osteoarthritis Patients Who Received Placebo in the K0701 Phase 2a TrialKang Stem Biotech Co., Ltd.Recruiting
NCT07754175Recruiting
—
A Multicenter, Open-Label, Single-Arm Extension Study to Evaluate the Safety and...Kang Stem Biotech Co., Lt...
NCT07753915
A Study on the Development and Application of a Cardiac Rehabilitation Nursing Intervention Protocol for Patients With First-Episode Acute Myocardial Infarction Following PCI, Based on a Socio-Ecological Theory ModelJinzhou Medical UniversityCompletedNot Applicable
NCT07753915Completed
Not Applicable
A Study on the Development and Application of a Cardiac Rehabilitation Nursing I...Jinzhou Medical Universit...
NCT07755397
First in Human Multicenter Open Name Dose-increase, Consolidation Method to Study Safety Drug-level in Blood & Drug Metabolism Clinical Activity of Oral JBI-778 in Lung Cancer Patients With, Without Brain Metastasis IDH Mutated WHO Grade 3,4 Recurrent Glioma, Salivary Glands TumorJubilant Therapeutics India LimitedRecruitingPhase 1
NCT07755397Recruiting
Phase 1
First in Human Multicenter Open Name Dose-increase, Consolidation Method to Stud...Jubilant Therapeutics Ind...
NCT07755150
A Study to Evaluate the Efficacy and Safety of DA-302168S Tablets in Subjects With Type 2 DiabetesChendu DIAO Pharmaceutical Group CO., LTD.Not Yet RecruitingPhase 2
NCT07755150Not Yet Recruiting
Phase 2
A Study to Evaluate the Efficacy and Safety of DA-302168S Tablets in Subjects Wi...Chendu DIAO Pharmaceutica...
NCT07755553
Effect of a Mushroom Extract-Containing Topical Cosmetic Formulation During Breast RadiotherapyAITEX Centro Investigación E InnovaciónCompletedNot Applicable
NCT07755553Completed
Not Applicable
Effect of a Mushroom Extract-Containing Topical Cosmetic Formulation During Brea...AITEX Centro Investigació...
NCT07755839
CanCOG®: Pilot Trial of Cognitive Rehabilitation for Cancer SurvivorsAveiro UniversityNot Yet RecruitingNot Applicable
NCT07755839Not Yet Recruiting
Not Applicable
CanCOG®: Pilot Trial of Cognitive Rehabilitation for Cancer SurvivorsAveiro University
NCT07755033
Personalized Nutritional Formula for ICU Patients: A Study on Prognosis and Multidimensional Health MarkersChinese Medical AssociationNot Yet RecruitingNot Applicable
NCT07755033Not Yet Recruiting
Not Applicable
Personalized Nutritional Formula for ICU Patients: A Study on Prognosis and Mult...Chinese Medical Associati...
NCT07754760
Essential Amino Acid Supplementation Enhances Post-prandial Amino Acid Availability Following a Standard-protein Breakfast in Older AdultsLeeds Beckett UniversityCompletedNot Applicable
NCT07754760Completed
Not Applicable
Essential Amino Acid Supplementation Enhances Post-prandial Amino Acid Availabil...Leeds Beckett University
NCT07755527
Healing After Injury to Reduce Opioid Use and Pain Through Preventive Engagement - Open TrialHenry Ford Health SystemNot Yet RecruitingNot Applicable
NCT07755527Not Yet Recruiting
Not Applicable
Healing After Injury to Reduce Opioid Use and Pain Through Preventive Engagement...Henry Ford Health System
NCT07755540
Group Music Therapy for Chronic Pain Management in Active Duty Service Members: A Randomized Controlled TrialDrexel UniversityRecruitingPhase 2
NCT07755540Recruiting
Phase 2
Group Music Therapy for Chronic Pain Management in Active Duty Service Members:...Drexel University
NCT07754721
Comprehensive Management Strategies for Gastroesophageal Reflux Disease: A Study of Multidimensional Interventions and Health ImpactsHualien Tzu Chi General HospitalRecruitingNot Applicable
NCT07754721Recruiting
Not Applicable
Comprehensive Management Strategies for Gastroesophageal Reflux Disease: A Study...Hualien Tzu Chi General H...
NCT07755163
Screening Cancer Readiness Through Education and Empowerment for Newcomer WomenErzincan Binali Yildirim UniversitesiNot Yet RecruitingNot Applicable
NCT07755163Not Yet Recruiting
Not Applicable
Screening Cancer Readiness Through Education and Empowerment for Newcomer WomenErzincan Binali Yildirim...
Result Breakdown
Not yet recruiting11 (55%)
Completed4 (20%)
Recruiting4 (20%)
Active, not recruiting1 (5%)
not_applicable13 (65%)
Phase 25 (25%)
Not Specified1 (5%)
Phase 11 (5%)